Loading...
Effects of increasing the PSA cutoff to perform additional biomarker tests before prostate biopsy
BACKGROUND: Multi-step testing might enhance performance of the prostate cancer diagnostic pipeline. Using PSA >1 ng/ml for first-line risk stratification and the Stockholm 3 Model (S3M) blood-test >10% risk of Gleason Score > 7 prostate cancer to inform biopsy decisions has been suggested....
Na minha lista:
| Udgivet i: | BMC Urol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5627473/ https://ncbi.nlm.nih.gov/pubmed/28974201 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12894-017-0281-8 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|